Austin W. Marxe & David M. Greenhouse’s Acadia Pharmaceuticals ACAD Stock Holding History

Austin W. Marxe & David M. Greenhouse’s Portfolio ACAD Stock Details ACAD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q3	$1.64M	Hold	66,357	–	–	0.22%	97
2014 Q2	$1.5M	Hold	66,357	–	–	0.19%	102
2014 Q1	$1.61M	Hold	66,357	–	–	0.18%	101
2013 Q4	$1.66M	Sell	66,357 -50,000	-43%	-$1.18M	0.18%	96
2013 Q3	$3.2M	Sell	116,357 -54,243	-32%	-$1.13M	0.39%	76
2013 Q2	$3.1M	Buy	+170,600	New	+$2.35M	0.42%	76

Other funds holding ACAD

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

JHIU

Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Austin W. Marxe & David M. Greenhouse's ACAD Position: Q3 2014 in Review

Austin W. Marxe & David M. Greenhouse held its Acadia Pharmaceuticals (ACAD) position steady in Q3 2014 at 66,357 shares worth $1.64M. The position accounts for 0.22% of the portfolio, ranked #97.

Austin W. Marxe & David M. Greenhouse first reported a position in ACAD in Q2 2013 and has held it in 6 quarters since. The position peaked at $3.2M in Q3 2013. 162 funds tracked by Wall St. Rank hold ACAD as of Q3 2014.

Austin W. Marxe & David M. Greenhouse held 66,357 shares of Acadia Pharmaceuticals worth $1.64M as of Q3 2014.
Austin W. Marxe & David M. Greenhouse left its Acadia Pharmaceuticals share count unchanged in Q3 2014.
Acadia Pharmaceuticals made up 0.22% of Austin W. Marxe & David M. Greenhouse's portfolio in Q3 2014, its #97 holding.
Austin W. Marxe & David M. Greenhouse first reported a position in Acadia Pharmaceuticals in Q2 2013 and has held it in 6 quarters since.
Austin W. Marxe & David M. Greenhouse's Acadia Pharmaceuticals position peaked at $3.2M in Q3 2013.
162 funds tracked by Wall St. Rank held Acadia Pharmaceuticals as of Q3 2014.

Based on Austin W. Marxe & David M. Greenhouse's 13F filing for Q3 2014, filed 14 Nov 2014.